As of 19 Nov 2026, Boston Medical Sciences has raised $34.7M across 1 verified round on record (amounts in other currencies converted to USD), plus 1 round still being checked; latest: ¥5.55B Series B led by Beyond Next Ventures, Global Brain and 1 other, announced 13 Nov 2026.
Boston Medical Sciences develops advanced medical technologies, including a non-invasive virtual colonoscopy system using AI for colorectal cancer detection, targeting healthcare providers and institutions.
b-ms.techTokyoHealthtechFounded 202347 employees (as of November 1, 2026)
4 sources · checked 4 times, last 9h ago
Source 1 describes the event as an additional investment, while the company's release identifies the announced financing as a Series B round; the company's release is preferred.
2 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
会社発表と記事は、シリーズA(プレシリーズAを含む)で9.3億円を調達した点で一致しています。明示的なリード投資家はありません。
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B | $34.7M ¥5.55B | 2026-11-13 | Beyond Next Ventures, Global Brain, Japan Growth Capital Investment | No recent discussion |
4 sources · checked 4 times, last 9h ago [ VERIFIED ] read against 4 sources Source 1 describes the event as an additional investment, while the company's release identifies the announced financing as a Series B round; the company's release is preferred. | ||||
Boston Medical Sciences develops AIM4CRC, an AI-powered virtual colonoscopy system designed to let medical providers screen for colorectal cancer without laxative preparation.
Checked against 8 sources 3d ago
| Series A シリーズA [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6.1M 9.3億円 | 2025-02-12 | not stated | No recent discussion |
2 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 sources
会社発表と記事は、シリーズA(プレシリーズAを含む)で9.3億円を調達した点で一致しています。明示的なリード投資家はありません。 [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: b-ms.tech, aitimes.media·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
Also named as backers in company research: NEDO ディープテック・スタートアップ支援事業(STSフェーズ/PCAフェーズ), Meiji Yasuda Future Innovation Fund L.P., TAKANAWA GATEWAY Global Co-Benefits Fund L.P.